Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Malignant pleural mesothelioma is an aggressive tumor that has a poor prognosis and is resistant to unimodal approaches. Multimodal treatment has provided encouraging results.Phase II, open-label study of the combination of chemotherapy (pemetrexed 500 mg/m²+cisplatin 75 mg/m² IV every 21 days × 3 c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rea Federico, Adolfo Favaretto, Giuseppe Marulli, Lorenzo Spaggiari, DePas Tommaso Martino, Ceribelli Anna, Adriano Paccagnella, Gino Crivellari, Russo Francesca, Matteo Ceccarelli, Kazeem Gbenga, Marchi Paolo, Francesco Facciolo
Médium: Artigo
Jazyk:angličtina
Vydáno: 2013
On-line přístup:https://doi.org/10.1186/1471-2407-13-22
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1186/1471-2407-13-22

Podobné jednotky